The Board of Oncodesign Société Anonyme (ENXTPA:ALONC) announced the spin-off of Oncodesign Precision Medicine (OPM) (ENXTPA : MLOPM) on September 28, 2022. As per the transaction, each Oncodesign shareholder will receive one OPM share for one Oncodesign Société Anonyme share held. The shareholders will also receive the cash distribution amounts to a total of € 2.3 million, at a rate of approximately 0.34 euros per Oncodesign share entitled to the distribution.

€0.817 per share 1 which was distributed to the shareholders of Oncodesign Services on October 5, 2022.